시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 고속 액체 크로마토그래피(HPLC) 시장 보고서(2025년)
High-Performance Liquid Chromatography Global Market Report 2025
상품코드 : 1775762
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,498,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,393,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,288,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

고속 액체 크로마토그래피 시장 규모는 향후 수년간 급성장이 예상됩니다. 2029년에는 CAGR 11.5%로 성장할 전망이며, 104억 달러로 성장이 예측됩니다. 예측 기간 성장은 의약품의 안전성 및 품질보증 증가, 정밀의료로부터의 수요, 대마 검사 확대, 환경 모니터링 증가, 메소드 개발의 증가에 기인할 것으로 보입니다. 예측 기간 주요 동향으로는 선진 검출기, 고 처리량 HPLC, 그린에서 지속가능한 HPLC, uHPLC 채택, lc-ms 통합 등이 있습니다.

향후 5년간의 성장률 11.5%라고 하는 예측은 이 시장의 전회 예측으로부터의 0.3%라고 하는 소폭의 감소를 반영하고 있습니다.이 감소는 주로 미국과 타국 간 관세의 영향에 의한 것입니다. 스위스나 독일에서 오는 HPLC 기기 및 화학품이 수입관세에 따라 비싸지기 때문에 제약사나 랩스의 경비가 증가해 미국에 직접적인 영향을 미칠 가능성이 높습니다. 이 영향은 상호 관세 및 무역 마찰이나 무역 제한의 격화에 의한 세계 경제나 무역에 대한 악영향에 의해 보다 광범위하게 미칠 것으로 생각됩니다.

만성 질환 증가는 향후 고속 액체 크로마토그래피(HPLC) 시장의 성장을 가속할 것으로 예측됩니다. 암, 심장병, 뇌졸중, 당뇨병, 관절염을 포함한 만성질환은 일반적으로 장기간 지속되고 지속적인 의료를 필요로 하는 질환입니다. HPLC는 의약품 분석에 사용되며 그 동일성을 확인하고 정량 데이터를 제공하며 질병 치료 효과를 모니터링합니다. 또한 의약품 승인 전 생물학적 및 치료학적 연구를 통해 인체의 정상 및 병리학적 과정에 대한 이해를 높일 수 있어 시장 성장에 기여하고 있습니다. 예를 들면, 미국을 거점으로 하는 임의 단체인 미국암협회는, 2022년에 새롭게 암으로 진단된 환자수는 약 190만 명, 암으로 인한 사망자수는 60만 9,360명이 된 것으로 평가하고 있습니다. 또한 2021년 12월에 발표된 국제당뇨병연합(IDF)의 보고서에 따르면 2021년 현재 20세에서 79세 사이의 당뇨병 환자는 약 5억 3,700만 명으로 평가되었으며, 2030년에는 6억 4,300만 명, 2045년에는 7억 8,300만 명으로 예측되고 있습니다. 이처럼 만성질환 유병률 상승이 고속액체 크로마토그래피 시장 확대를 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

High-performance liquid chromatography (HPLC) is a technique employed to separate, identify, and quantify the components within a mixture. It plays a crucial role in the quantitative determination of plasma levels of drugs and their metabolites, particularly in the development of novel medications and therapy monitoring.

The primary products associated with high-performance liquid chromatography include instruments, consumables, accessories, and software. HPLC instrumentation typically comprises nine basic components, incorporating data collection, an output system, and connective tubing and fittings. These components find application in various fields such as clinical research, diagnostics, forensics, and others. The technology is utilized by diverse end-users, including pharmaceutical and biotechnology companies, academic and research institutes, food and beverage companies, hospitals and clinics, environmental agencies, and other entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The escalating U.S. tariffs and rising trade tensions in spring 2025 are expected to significantly affect the chemicals sector, which is facing a disproportionate impact-particularly from tariffs on petrochemicals and intermediates, where affordable domestic alternatives are limited. Specialty chemical producers, who rely heavily on Chinese raw materials, are encountering production disruptions. Meanwhile, fertilizer manufacturers are seeing their profit margins squeezed due to tariffs on phosphate imports. In response, companies are increasing investments in R&D for bio-based alternatives, forming procurement alliances to strengthen purchasing power, and relocating production to tariff-neutral countries like Saudi Arabia.

The high-performance liquid chromatography market research report is one of a series of new reports from The Business Research Company that provides high-performance liquid chromatography market statistics, including high-performance liquid chromatography industry global market size, regional shares, competitors with a high-performance liquid chromatography market share, detailed high-performance liquid chromatography market segments, market trends and opportunities, and any further data you may need to thrive in the high-performance liquid chromatography industry. This high-performance liquid chromatography market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The high-performance liquid chromatography market size has grown strongly in recent years. It will grow from $6.28 billion in 2024 to $6.73 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increase in pharmaceutical research, rise in food and beverage analysis, rise in demand from environmental testing, increase in increased use in clinical diagnostics, rise in research and development.

The high-performance liquid chromatography market size is expected to see rapid growth in the next few years. It will grow to $10.4 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to increasing drug safety and quality assurance, demand from precision medicine, expansion of cannabis testing, increasing environmental monitoring, increasing method development. Major trends in the forecast period include advanced detectors, high-throughput hplc, green and sustainable hplc, uhplc adoption, lc-ms integration.

The forecast of 11.5% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US by increasing expenses for pharmaceutical and research labs, as HPLC equipment and chemicals from Switzerland and Germany become costlier due to import duties.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

An increase in the prevalence of chronic diseases is anticipated to drive the growth of the high-performance liquid chromatography (HPLC) market moving forward. Chronic diseases, including cancer, heart disease, stroke, diabetes, and arthritis, are conditions that typically persist for extended periods and require ongoing medical care. HPLC is used to analyze medications to verify their identity, provide quantitative data, and monitor the effectiveness of disease treatment. It can also enhance the understanding of both normal and pathological processes in the human body through biological and therapeutic research before drug approval, thereby contributing to market growth. For example, in 2022, the American Cancer Society, a U.S.-based voluntary organization, estimated that there would be approximately 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. Additionally, a report from the International Diabetes Federation (IDF), published in December 2021, indicated that around 537 million individuals aged 20 to 79 were estimated to have diabetes in 2021, with projections of 643 million by 2030 and 783 million by 2045. Thus, the rising prevalence of chronic diseases is driving the expansion of the high-performance liquid chromatography market.

An increasing number of ongoing clinical trials is expected to drive the growth of the high-performance liquid chromatography (HPLC) market in the future. Clinical trials are research studies conducted with human participants to assess the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. HPLC plays a crucial role in clinical trials by delivering precise analyses of pharmaceutical compounds and biomarkers, ensuring drug safety and efficacy. It aids in quality control, pharmacokinetic studies, and biomarker quantification, supporting drug development and enhancing patient safety. For example, in October 2023, ClinicalTrials.gov, a component of the National Institutes of Health (NIH), a U.S.-based government agency responsible for conducting and supporting medical research, reported an increase in registered studies from 437,523 in 2022 to 468,457 across all 50 states and 221 countries. Additionally, it was noted that 143,613 studies (31% of the total) are registered in the U.S., while 251,159 studies (54% of the total) are registered outside the U.S. Therefore, the growing number of ongoing clinical trials is driving the expansion of the high-performance liquid chromatography market.

Key companies in the market are developing advanced high-performance liquid chromatography (HPLC) technologies, such as integrated HPLC, for various research applications. For example, in April 2024, Waters Corporation, a U.S.-based life sciences firm, introduced the Alliance iS Bio. This system is specifically designed for biopharmaceutical applications, ensuring precise and reliable separation of complex biological molecules. It features smart technology that aids quality control analysts, thereby reducing operational errors and enhancing system performance. The system addresses up to 40% of common errors, which minimizes the time spent investigating failed runs and out-of-spec results. By improving workflow efficiency, it allows for faster and more accurate results in biopharma quality control processes.

Major players in the high-performance liquid chromatography market are intensifying their focus on introducing cutting-edge systems to gain a competitive advantage. Waters Corporation, a leading US-based manufacturer of laboratory instruments, exemplifies this trend with the launch of the next-generation Alliance iS High-Performance Liquid Chromatography (HPLC) System in March 2023. This intelligent and advanced instrument is tailored to meet the distinctive needs of quality control (QC) laboratories. The Alliance iS HPLC System is engineered to reduce laboratory errors by up to 40%, featuring enhanced temperature control in the sample manager, column manager, and detector, making it adaptable to global requirements. Noteworthy features include tool-free fittings, clearly labeled and organized solvent lines, and auto-recognition of Waters eConnect HPLC columns to prevent leaks and user errors during setup. The system is designed with intuitive mechanisms for fast feedback, a touchscreen interface for troubleshooting and maintenance guidance, and optimized accessibility to serviceable components, ensuring efficient operation and maximizing return on investment.

In July 2024, Catalyze Partners, a U.S.-based firm focused on transforming innovative technologies, acquired Axcend, LLC, for an undisclosed sum. This acquisition enhances Catalyze Partners' capacity to address the growing demand for advanced analytical solutions in sectors such as pharmaceuticals, environmental monitoring, and chemical manufacturing. Axcend, LLC, is a U.S.-based company specializing in high-performance liquid chromatography systems.

Major companies operating in the high-performance liquid chromatography market include Waters Corporation, Agilent Technologies Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Merck Millipore, Hitachi Ltd., Phenomenex Inc., JASCO Corporation, Gilson Inc., Knauer GmbH, SIELC Technologies, Tosoh Bioscience LLC, YMC Co. Ltd., GL Sciences Inc., Sepax Technologies Inc., Restek Corporation, Hamilton Company, ACE HPLC Columns, Advanced Chromatography Technologies Ltd., Analytical Sales and Services Inc., Chromatography Research Supplies Inc., Daicel Corporation, Eksigent Technologies LLC, Hichrom Limited

North America was the largest region in the high-performance liquid chromatography market analysis in 2024. Asia-Pacific is expected to be the fastest-growing region in the global high performance liquid chromatography market during the forecast period. The regions covered in the global high performance liquid chromatography market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the high-performance liquid chromatography market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The high-performance liquid chromatography market includes revenues earned by entities by providing reverse phase columns, normal phase columns, ion exchange columns, and size exclusion columns. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

High-Performance Liquid Chromatography Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on high-performance liquid chromatography market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for high-performance liquid chromatography ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The high-performance liquid chromatography market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. High-Performance Liquid Chromatography Market Characteristics

3. High-Performance Liquid Chromatography Market Trends And Strategies

4. High-Performance Liquid Chromatography Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global High-Performance Liquid Chromatography Growth Analysis And Strategic Analysis Framework

6. High-Performance Liquid Chromatography Market Segmentation

7. High-Performance Liquid Chromatography Market Regional And Country Analysis

8. Asia-Pacific High-Performance Liquid Chromatography Market

9. China High-Performance Liquid Chromatography Market

10. India High-Performance Liquid Chromatography Market

11. Japan High-Performance Liquid Chromatography Market

12. Australia High-Performance Liquid Chromatography Market

13. Indonesia High-Performance Liquid Chromatography Market

14. South Korea High-Performance Liquid Chromatography Market

15. Western Europe High-Performance Liquid Chromatography Market

16. UK High-Performance Liquid Chromatography Market

17. Germany High-Performance Liquid Chromatography Market

18. France High-Performance Liquid Chromatography Market

19. Italy High-Performance Liquid Chromatography Market

20. Spain High-Performance Liquid Chromatography Market

21. Eastern Europe High-Performance Liquid Chromatography Market

22. Russia High-Performance Liquid Chromatography Market

23. North America High-Performance Liquid Chromatography Market

24. USA High-Performance Liquid Chromatography Market

25. Canada High-Performance Liquid Chromatography Market

26. South America High-Performance Liquid Chromatography Market

27. Brazil High-Performance Liquid Chromatography Market

28. Middle East High-Performance Liquid Chromatography Market

29. Africa High-Performance Liquid Chromatography Market

30. High-Performance Liquid Chromatography Market Competitive Landscape And Company Profiles

31. High-Performance Liquid Chromatography Market Other Major And Innovative Companies

32. Global High-Performance Liquid Chromatography Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The High-Performance Liquid Chromatography Market

34. Recent Developments In The High-Performance Liquid Chromatography Market

35. High-Performance Liquid Chromatography Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기